Sponsor-Investigators

Michael B. Atkins

HCRN-GU16-260

Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma

Status

Open to Accrual

Cancer Types

Kidney

Locations

Beth Israel Deaconess Medical Center, Cleveland Clinic Cancer Center, Columbia University Irving Medical Center, Connecticut, Fox Chase Cancer Center, Georgetown Lombardi Comprehensive Cancer Center, Illinois, Massachusetts, New York, Ohio, Penn Medicine Abramson Cancer Center, Pennsylvania, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Texas, University of Illinois Cancer Center, UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Washington, D.C., Winship Cancer Institute of Emory University, Yale Cancer Center